Background People with asthma may experience exacerbations or" attacks" during which
their symptoms worsen and additional treatment is required. Written action plans may …

Introduction Chronic obstructive pulmonary disease (COPD) is the third leading cause of
death worldwide. COPD results from chronic inflammation of the lungs. Current treatments …

Introduction A large group of patients with chronic obstructive pulmonary disease (COPD)
are exposed to an overload of oral corticosteroids (OCS) due to repeated exacerbations …

The use of systemic corticosteroids, together with bronchodilators and oxygen therapy, has
become established for the management of acute asthma. These agents are undoubtedly …

BACKGROUND: Inhaled corticosteroids (ICSs) are widely used in the treatment of
obstructive lung disease. ICSs have been shown to be systemically absorbed. The …

Aim To determine the risk of type 2 diabetes onset associated with accumulated inhaled
corticosteroids (ICS) dose during the previous year in patients with chronic obstructive …

Background The use of human umbilical cord mesenchymal stem cells (UC-MSCs) has
shown promise in improving the pathophysiological characteristics of rats with chronic …

We report a case of invasive pulmonary filamentous fungal infection in a patient with chronic
obstructive pulmonary disease who was treated with a conventional dose of inhaled …

The Food and Drug Administration approves about 25 new drug entities each year, and new
interactions are also reported for drugs already in use. Only recently have serious drug …

Both oral and inhaled corticosteroids have clinically significant effects on symptoms,
exacerbations, health status, and lung function in asthma, and to a lesser extent in chronic …